Menu
APIs Under Commercialization
| S.No. | PRODUCT NAME | CAS No. | Pharmacopeia | Therapeutic Use | Tech. Pack |
|---|---|---|---|---|---|
| 1 | Rotigotine | 99755-59-6 | USP/Ph.Eur/IH | Anti-Parkinson | ✓ |
| 2 | 375815-87-5 | In-house | Anti-Smoking | ✓ | |
| 3 | Ranolazine | 95635-55-5 | In-house | Anti-Angina | ✓ |
| 4 | Raloxifene Hydrochloride | 82640-04-8 | In-house/Ph.Eur/USP | Osteoporosis | - |
| 5 | Silodosin | 160970-54-7 | In-house | Benign Prostatic Hyperplasia | - |
| 6 | Sitagliptin | 486460-32-6 | In-house | Anti-Hyperglycemic | - |
| 7 | Nebivolol Hydrochloride | 152520-56-4 | In-house/IP | Anti-Hypertensive | - |
| 8 | Dapoxetine Hydrochloride | 129938-20-1 | In-house | Premature Ejaculation | - |
| 9 | Darifenacin Hydrobromide | 133099-07-7 | In-house | Urinary Incontinence | - |
| 10 | Lacosamide | 175481-36-4 | - | Anti-Epileptic | - |
| 11 | Bilastine | 202189-78-4 | - | Anti-Histamine | - |
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
| S.No. | PRODUCT NAME | CAS No. | Pharmacopeia | Therapeutic Use | Tech. Pack |
|---|---|---|---|---|---|
| 1 | Rotigotine | 99755-59-6 | USP/Ph.Eur/IH | Anti-Parkinson | ✓ |
| 2 | 375815-87-5 | In-house | Anti-Smoking | ✓ | |
| 3 | Ranolazine | 95635-55-5 | In-house | Anti-Angina | ✓ |
| 4 | Raloxifene Hydrochloride | 82640-04-8 | In-house/Ph.Eur/USP | Osteoporosis | - |
| 5 | Silodosin | 160970-54-7 | In-house | Benign Prostatic Hyperplasia | - |
| 6 | Sitagliptin | 486460-32-6 | In-house | Anti-Hyperglycemic | - |
| 7 | Nebivolol Hydrochloride | 152520-56-4 | In-house/IP | Anti-Hypertensive | - |
| 8 | Dapoxetine Hydrochloride | 129938-20-1 | In-house | Premature Ejaculation | - |
| 9 | Darifenacin Hydrobromide | 133099-07-7 | In-house | Urinary Incontinence | - |
| 10 | Lacosamide | 175481-36-4 | - | Anti-Epileptic | - |
| 11 | Bilastine | 202189-78-4 | - | Anti-Histamine | - |
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
